A pooled analysis of five RCTs comparing TCZ with conventional DMARDs reported that depression severity (based on medical records, stratified by timing and confirmed by clinical investigators) was associated with reduced rates of clinical remission (measured by CDAI and SDAI), although no such association was found with inflammatory markers such as CRP [32]. The gene discussed is CRP; the disease is depressive symptom measurement.